A great event to walk off the Christmas celebrations, and to kick start your New Year fitness regime! There are Full Marathon, Half Marathon & 10K options, both starting & finishing at The Oval ...
A challenge event you can take on at your pace. The Jurassic Coast Challenge invites you to walk, jog or run a distance of your choice, along a signed route, with free food and drink at regular rest ...
People with Down’s syndrome are born with an extra piece of DNA in all their cells. This means they have an extra copy of the APP (amyloid precursor protein) gene. This leads to the build-up of ...
A challenge event you can take on at your pace. The Thames Path Ultra Challenge invites you to walk, jog or run a distance of your choice, along a signed route, with free food and drink at regular ...
A challenge event you can take on at your pace. The Kent Downs 50 Challenge invites you to walk, jog or run a distance of your choice, along a signed route, with free food and drink at regular rest ...
The start of a new year is the perfect time to check in on your brain health. Alzheimer’s Research UK’s Information Services ...
Complete 28 miles throughout February in whichever way you like. Whether you walk, run, cycle or swim, make every mile count and aim to raise £100 for vital dementia research. Join our Facebook group ...
We’re delighted to have received so many poster abstracts for consideration for the poster presentations! Delegates will have the opportunity to visit the posters and engage with the presenters during ...
At Alzheimer’s Research UK, we use door-to-door and private site fundraising (where fundraisers work in locations like shopping centres and train stations). You may speak to our fundraisers at your ...
In our 2024 Spring Raffle, £51,815 was raised from ticket sales – 12.26% being spent on prizes, 39.00% on the expenses of running the raffle and 48.75% going on to fund the work of Alzheimer’s ...
Dr Susan Kohlhaas, our Executive Director of Research and Partnerships talks to us about the dementia drugs that could follow lecanemab and donanemab. And exciting new work that’s going to boost our ...